3D modelling of heart cells, brain networks for balance and metabolic disorders

Enjoy fascinating presentations from young researchers and leading scientists at the free Jung Symposium on 3rd May 2024 via live stream

Hamburg, 2nd April 2024. Can we alleviate balance problems in the case of neurological conditions such as stroke by decoding the brain networks for balance? Can 3D models and 3D printing technology contribute to improving research into heart disease? How exactly is energy and sugar metabolism regulated by the central nervous system? And what mechanisms are used to break down fat in cells? Fascinating questions that all have one thing in common: they are the subject of outstanding research work by talented young researchers and renowned personalities from the world of contemporary science, who have been awarded by the Jung Foundation. These questions will be answered at the fourth Jung Symposium ‘Excellence in human medicine 2024’: Metabolism researcher Professor Rudolf Zechner, Professor of Endocrinology Jens Brüning, Doctor of Cardiology Christine Maria Poch and Doctor of Neurology Maximilian U. Friedrich will offer their individual insights into their research results and will be on hand to answer questions. The symposium can be attended in person in Hamburg from 13:00 to 16:00 on 3rd May or can be followed remotely via live stream. All the details about the current programme and a registration form are available at https://jung-stiftung.de/en/symposium-2024/. The symposium will take place in English. Participation is free. 

Here you can find the press release for download.

Here you can find the pictures for download.

 

Zur Pressmitteilung

Award ceremony: 540,000 euros for top researchers

Jung Foundation for Science and Research honours Özlem Türeci, Stefan Rose-John and Achmed Mrestani with highly endowed medicine prizes 

 

Hamburg, May 5, 2023. Yesterday evening, the Jung Foundation for Science and Research awarded its medical prizes, which are among the most highly endowed in Europe. The laureates: Professor Dr med. Dr h.c. mult. Özlem Türeci, Professor Dr rer. nat. Stefan Rose-John and Dr med. Achmed Mrestani were honoured with a total of 540,000 euros for their pioneering research. With personal speeches of thanks, they accepted the awards in front of an invited audience. 

Download the press release here.

Download images from the event here.

 

Zur Pressmitteilung

HIV-1: Antibodies with low viral escape identified

 

A promising option for the prevention and treatment of HIV-1 infections is the use of broadly neutralizing antibodies targeting the HIV-1 envelope protein. However, their clinical application may be limited if the virus develops resistance. With the participation of Ernst Jung career award 2018 winner Till Schoofs, a highly broad and potent antibody has now been discovered that targets the CD4 binding site of HIV-1[1].

Zur Pressmitteilung

Ernst Jung Award winner receives Leibniz Prize

 

Where there is one prize, a second is soon to follow: In March, our award winner 2018 Professor Dr. Marco Prinz was awarded the prestigious Gottfried Wilhelm Leibniz Prize. The German Research Foundation (DFG) thus honours his outstanding work in the field of neuroimmunology.

Zur Pressmitteilung

Deutschlandstipendien: Jung Foundation for Science and Research supports medical students of the University of Hamburg

 

For the third time in a row, the Hamburg Jung Foundation for Science and Research is contributing to the Deutschlandstipendien at the University of Hamburg. Students that are especially gifted, engaged in voluntary work or have special needs receive monthly financial support. The University of Hamburg has been awarding Deutschlandstipendien in all faculties since 2015. In accordance with its objective, the Jung Foundation supports medicine students.

Zur Pressmitteilung

Postponed: Jung-Nacht der Medizinischen Forschung

 

Due to the spread of the coronavirus SARS-CoV-2 and the resulting restrictions to public life, we have decided to postpone our award ceremony to 20 May 2021.

Zur Pressmitteilung